Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

EPIRUBICIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Epirubicin Hydrochloride, and what substitute generic drugs are available?

Epirubicin Hydrochloride is a drug marketed by Hospira, Fresenius Kabi Usa, Fresenius Kabi Oncol, Impax Labs Inc, Ebewe Pharma, Actavis Totowa, Cipla Ltd, Akorn Inc, Mustafa Nevsat, Mylan Institutional, Hisun Pharm Hangzhou, West-ward Pharms Int, and Mylan Labs Ltd. and is included in fourteen NDAs.

The generic ingredient in EPIRUBICIN HYDROCHLORIDE is epirubicin hydrochloride. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epirubicin hydrochloride profile page.

Summary for Tradename: EPIRUBICIN HYDROCHLORIDE

Patents:0
Applicants:13
NDAs:14
Suppliers / Packagers: see list9
Bulk Api Vendors: see list75
Clinical Trials: see list1,081
Patent Applications: see list4,175
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EPIRUBICIN HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: EPIRUBICIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd
EPIRUBICIN HYDROCHLORIDE
epirubicin hydrochloride
INJECTABLE;INJECTION091599-002Mar 12, 2012RXNoNo► Subscribe► Subscribe
Hisun Pharm Hangzhou
EPIRUBICIN HYDROCHLORIDE
epirubicin hydrochloride
INJECTABLE;INJECTION090075-002Mar 25, 2010RXNoNo► Subscribe► Subscribe
West-ward Pharms Int
EPIRUBICIN HYDROCHLORIDE
epirubicin hydrochloride
INJECTABLE;INJECTION065289-001Jun 27, 2007RXNoNo► Subscribe► Subscribe
Hospira
EPIRUBICIN HYDROCHLORIDE
epirubicin hydrochloride
INJECTABLE;IV (INFUSION)050807-001Sep 15, 2006DISCNNoNo► Subscribe► Subscribe
Actavis Totowa
EPIRUBICIN HYDROCHLORIDE
epirubicin hydrochloride
INJECTABLE;INJECTION065445-002Sep 18, 2008RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc